Sign Up to like & get
recommendations!
0
Published in 2020 at "Neuro-oncology"
DOI: 10.1093/neuonc/noaa215.081
Abstract: Histone H3.3 G34R/V mutations are drivers of pediatric high-grade glioma (pHGG). However, the mechanism(s) responsible for G34R/V induced tumorigenesis are unclear. We observed that pHGG cells with H3.3 G34 mutations have significantly reduced phosphorylation at…
read more here.
Keywords:
g34r mutations;
g34r;
glioma;
high grade ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2024 at "Neuro-Oncology"
DOI: 10.1093/neuonc/noae165.1160
Abstract: Pediatric high-grade gliomas (pHGG) harboring H3.3 K27M/G34R mutations present formidable challenges in treatment due to their aggressiveness and resistance to standard chemotherapy. Our preliminary investigations have shown promising results, indicating that combining 2-deoxyglucose (2DG), a…
read more here.
Keywords:
2dg resistant;
phgg;
g34r mutations;
gliomas ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2019 at "Neuro-Oncology"
DOI: 10.1093/neuonc/noz175.802
Abstract: Alterations in histone H3.3 are common driver mutations in high-grade pediatric gliomas, but the central oncogenic mechanisms remain an open question. To identify important mutant H3.3 effectors, we used CRISPR-Cas9 to precisely introduce H3.3 K27M…
read more here.
Keywords:
g34r mutations;
k27m g34r;
glioma cells;
glioma ... See more keywords